Semax

Semax is a synthetic heptapeptide derived from ACTH, primarily used for neuroprotection and cognitive enhancement.

Its benefits are driven by two main mechanisms: upregulating Brain-Derived Neurotrophic Factor (BDNF) to support neurogenesis and synaptic plasticity, and modulating dopamine and serotoninpathways to improve focus and mood without the crashes associated with stimulants.

Key reported benefits include:

• Cognitive Enhancement: Improves focus, memory, learning capacity, and mental clarity by supporting neuroplasticity and cerebral blood flow.
• Neuroprotection: Protects neurons from damage caused by ischemia, oxidative stress, and inflammation, making it useful for stroke recovery and traumatic brain injury.
• Stress and Mood Regulation: Reduces anxiety and improves emotional stability by buffering the stress response and modulating neurotransmitter systems.
• No Stimulant Crash: Unlike traditional stimulants, Semax builds cognitive infrastructure rather than frcing neurotransmitter release, resulting in sustained attention without jitteriness or tolerance buildup.

While Semax is an approved pharmaceutical in Russia for conditions like stroke recovery and optic nerve disease, it remains unapproved in the US and EU.